Tony tucks into some fresh biotech stocks on that he will be keenly watching after a sector down period has left some bargains on the menu.

Alphabet (Google) is investing in biotech penny stocks. Should you? Explore Alphabet's investment strategy and discover potential penny stocks to consider.

Key Insights Significant control over IO Biotech by private equity firms implies that the general public has more ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

Following closely was ARK’s investment in Tempus AI Inc (TEM), where the firm bought 158,051 shares across its ARKK and ARKG ETFs, totaling $8,833,470. This purchase continues a recent trend of ARK ...

This cancer treatment stock is nearing a buy point of a base. Shares have already gained 50% so far this year.

Following a surge of 52.47% during regular trading session on Tuesday, Polyrizon Ltd (NASDAQ: PLRZ) witnessed a dip of 12.02% ...

Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants.

Onconetix said its shareholders will own 10% of the combined company upon completion of the deal, slated to close in the fourth quarter, while investors in Ocuvex, which is focused on developing ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the ...

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best oversold NASDAQ stocks to buy now. On July 11, BTIG analyst Julian ...